ArticleCancers2021

Long-Term Outcome and Role of Biology within Risk-Adapted Treatment Strategies: The Austrian Neuroblastoma Trial A-NB94.

Stefan Fiedler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.